BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1112981)

  • 21. Proteolysis of C2 and factor B: analyses of cleavage products by one- and two- dimensional peptide mapping.
    Ngan BY; Minta JO
    Mol Immunol; 1981 Dec; 18(12):1035-47. PubMed ID: 7038446
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of trypsin cleavage on the structure and function of human C4.
    Malmheden Yman I; Lundwall A; Stålenheim G; Sjöquist J
    FEBS Lett; 1981 Sep; 132(2):187-92. PubMed ID: 7297691
    [No Abstract]   [Full Text] [Related]  

  • 23. Cleavage of glucagon by alpha- and beta-trypsin.
    Keil-Dlouhá V; Zylber N; Tong N; Keil B
    FEBS Lett; 1971 Sep; 16(4):287-290. PubMed ID: 11945963
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular and expression analysis of complement component C5 in the nurse shark (Ginglymostoma cirratum) and its predicted functional role.
    Graham M; Shin DH; Smith SL
    Fish Shellfish Immunol; 2009 Jul; 27(1):40-9. PubMed ID: 19410004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular cloning and sequencing of porcine C5 gene and its association with immunological traits.
    Kumar KG; Ponsuksili S; Schellander K; Wimmers K
    Immunogenetics; 2004 Mar; 55(12):811-7. PubMed ID: 14770272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complement component C5 of the common carp (Cyprinus carpio): cDNA cloning of two distinct isotypes that differ in a functional site.
    Kato Y; Nakao M; Mutsuro J; Zarkadis IK; Yano T
    Immunogenetics; 2003 Feb; 54(11):807-15. PubMed ID: 12618914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covalent binding and hemolytic activity of complement proteins.
    Law SK; Lichtenberg NA; Levine RP
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7194-8. PubMed ID: 6938964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-enzymic activation of the covalent binding reaction of the complement protein C3.
    Law SK
    Biochem J; 1983 May; 211(2):381-9. PubMed ID: 6870837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages.
    Kipnis TL; David JR; Alper CA; Sher A; da Silva WD
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):602-5. PubMed ID: 6454138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory mediators released by complement-derived peptides.
    Bult H; Herman AG
    Agents Actions; 1983 Aug; 13(5-6):405-14. PubMed ID: 6416038
    [No Abstract]   [Full Text] [Related]  

  • 31. The membrane attack complex.
    Müller-Eberhard HJ
    Springer Semin Immunopathol; 1984; 7(2-3):93-141. PubMed ID: 6387983
    [No Abstract]   [Full Text] [Related]  

  • 32. Activated complement and anaphylatoxins increase the in vitro production of prostacyclin by rabbit aorta endothelium.
    Rampart M; Bult H; Herman AG
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):158-65. PubMed ID: 6346110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
    Wetsel RA; Kolb WP
    J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement-independent adherence of Escherichia coli to complement receptors in vitro.
    Fine DP; Harper BL; Carpenter ED; Davis CP; Cavallo T; Guckian JC
    J Clin Invest; 1980 Sep; 66(3):465-72. PubMed ID: 6105165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coli.
    Mandecki W; Mollison KW; Bolling TJ; Powell BS; Carter GW; Fox JL
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3543-7. PubMed ID: 3889908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid sequence of the trypsin-generated C3d fragment from human complement factor C3.
    Hellman U; Eggertsen G; Engström A; Sjöquist J
    Biochem J; 1985 Sep; 230(2):353-61. PubMed ID: 3876831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency.
    Wheat WH; Wetsel R; Falus A; Tack BF; Strunk RC
    J Exp Med; 1987 May; 165(5):1442-7. PubMed ID: 3572304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function.
    Nilsson B; Ekdahl KN; Svarvare M; Bjelle A; Nilsson UR
    Clin Exp Immunol; 1990 Nov; 82(2):262-7. PubMed ID: 2146995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.
    Nilsson B; Nilsson Ekdahl K; Avila D; Nilsson UR; Lambris JD
    Biochem J; 1990 May; 268(1):55-61. PubMed ID: 1693076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
    Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.